PHRRF (PharmaTher Holdings) Marketable Securities: $0.05 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PharmaTher Holdings Marketable Securities?

PharmaTher Holdings PHRRF +3.40% Marketable Securities is $0.05 Mil as of Feb. 2026. The stock has 1 warning sign investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. PharmaTher Holdings's Marketable Securities for the quarter that ended in Feb. 2026 was $0.05 Mil.

PharmaTher Holdings's annual Marketable Securities declined from May. 2023 ($0.25 Mil) to May. 2024 ($0.12 Mil) but then increased from May. 2024 ($0.12 Mil) to May. 2025 ($0.14 Mil).

PharmaTher Holdings  (OTCPK:PHRRF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

PharmaTher Holdings Marketable Securities Related Terms

PharmaTher Holdings Marketable Securities Historical Data

* Premium members only.

The historical data trend for PharmaTher Holdings's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaTher Holdings Marketable Securities Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23 May24 May25
Marketable Securities
2.56 2.31 0.25 0.12 0.14

PharmaTher Holdings Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.14 0.07 0.05 0.05

PharmaTher Holdings Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.05 Mil mean?
PharmaTher Holdings (PHRRF) has a Marketable Securities of $0.05 Mil as of Feb. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on PharmaTher Holdings and its competitors.
Is PharmaTher Holdings' Marketable Securities too high?
PharmaTher Holdings' current Marketable Securities is $0.05 Mil.
How does PharmaTher Holdings' Marketable Securities compare to VRTX and REGN?
PharmaTher Holdings' Marketable Securities of $0.05 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on PharmaTher Holdings and its competitors. PharmaTher Holdings's current Marketable Securities is $0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaTher Holdings stock overvalued right now?
PharmaTher Holdings (PHRRF) has a current Marketable Securities of $0.05 Mil. The current Marketable Securities is $0.05 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For PharmaTher Holdings (PHRRF), the current Marketable Securities is $0.05 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaTher Holdings Business Description

Other Exchanges NCC0:GermanyPHRM:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch and others.